Stratton Management’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
$4.19M Buy
42,099
+2,106
+5% +$206K 0.51% 76
2015
Q3
$3.65M Sell
39,993
-3,020
-7% -$303K 0.42% 101
2015
Q2
$4.56M Sell
43,013
-4,192
-9% -$464K 0.2% 134
2015
Q1
$5.39M Sell
47,205
-3,646
-7% -$416K 0.22% 135
2014
Q4
$5.6M Sell
50,851
-685
-1% -$72.2K 0.23% 133
2014
Q3
$5.03M Sell
51,536
-6,098
-11% -$600K 0.23% 123
2014
Q2
$5.81M Buy
57,634
+1,943
+3% +$190K 0.24% 128
2014
Q1
$5.11M Buy
55,691
+2,042
+4% +$188K 0.24% 127
2013
Q4
$4.85M Sell
53,649
-2,718
-5% -$235K 0.23% 129
2013
Q3
$4.5M Buy
56,367
+2,848
+5% +$224K 0.23% 130
2013
Q2
$3.89M Buy
+53,519
New +$4M 0.23% 133

Other funds holding ZBH

Stratton Management's ZBH Position: Q4 2015 in Review

Stratton Management increased its Zimmer Biomet (ZBH) stake by 5.3% in Q4 2015, buying an estimated $206K and bringing the position to 42,099 shares worth $4.19M. The position accounts for 0.51% of the portfolio, ranked #76.

Stratton Management first reported a position in ZBH in Q2 2013 and has held it in 11 quarters since. The position peaked at $5.81M in Q2 2014. 740 funds tracked by Wall St. Rank hold ZBH as of Q4 2015.

  • Stratton Management held 42,099 shares of Zimmer Biomet worth $4.19M as of Q4 2015.
  • Stratton Management bought 2,106 Zimmer Biomet shares in Q4 2015, an estimated $206K.
  • Zimmer Biomet made up 0.51% of Stratton Management's portfolio in Q4 2015, its #76 holding.
  • Stratton Management first reported a position in Zimmer Biomet in Q2 2013 and has held it in 11 quarters since.
  • Stratton Management's Zimmer Biomet position peaked at $5.81M in Q2 2014.
  • 740 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2015.

Based on Stratton Management's 13F filing for Q4 2015, filed 11 Feb 2016.